E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/17/2006 in the Prospect News Biotech Daily.

Cowen hires Kammerman as medical technology analyst

New York, May 17 - Cowen & Co. said it hired Eli Kammerman as senior analyst covering the medical technology sector.

"Eli's addition to Cowen and Company will extend our areas of coverage into several medical technology categories. Given his extensive experience in the health care industry, combined with his strong financial background, we are proud to add such a highly-respected analyst to our research team," said Barry Tarasoff, Cowen's director of research and Kammerman's new boss.

Kammerman was previously at Cathay Financial where he was a medical products analyst. He has 11 years' experience in the health care industry, including Pharmacia Diagnostics, Genex Corp. and Novartis Pharmaceuticals, and 10 years at Wall Street firms, including Merrill Lynch and Salomon Brothers as well as Cathay.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.